NCT03040661

Brief Summary

Patients who undergo ablation for AF typically have 2 sheaths placed in each groin, including a large sheath when the Cryo Balloon is used for pulmonary vein isolation. During the procedure, heparin is administered to maintain a target ACT \> 300 seconds. At the conclusion of the procedure, the venous sheaths are removed and hemostasis is obtained. There are at least 2 ways of obtaining hemostasis after venous access. In the manual hemostasis approach, an ACT is checked and protamine is administered. The ACT is rechecked 20" later, and if \< 220 msec, the sheaths are pulled and hemostasis is achieved with manual pressure (Manual Hemostasis Group). Another approach is to place a Figure of 8 suture around the sheaths in each groin to achieve hemostasis as the sheaths are removed, and therefore obviate the need for assessment of the ACT, protamine administration, and manual pressure (Figure of 8 Group).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for not_applicable atrial-fibrillation

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable atrial-fibrillation

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 2, 2017

Completed
27 days until next milestone

Study Start

First participant enrolled

March 1, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
3.6 years until next milestone

Results Posted

Study results publicly available

January 11, 2022

Completed
Last Updated

January 11, 2022

Status Verified

December 1, 2021

Enrollment Period

1 year

First QC Date

January 24, 2017

Results QC Date

December 6, 2019

Last Update Submit

December 23, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Time Required to Achieve Hemostasis

    Time Required to Achieve Hemostasis (minutes)

    Time (minutes) from sheath removal till hemostasis achieved

  • Time Required From the Completion of the Ablation Portion of the Procedure Until the Patient Leaves the EP Lab.

    Time required from the completion of the ablation portion of the procedure until the patient leaves the EP Lab (minutes)

    Time (minutes) from completion of procedure till patient leaves room

Secondary Outcomes (1)

  • Percent Groin Complications in Figure of 8 Suture Technique Group Compared to Manual Hemostasis Group

    Assessed after sheath removal till patient discharge

Study Arms (2)

Figure of 8 Suture

EXPERIMENTAL

Hemostasis after an ablation for atrial fibrillation with a figure of 8 suture.

Procedure: Ablation for atrial fibrillation.

Manual Hemostasis Group

ACTIVE COMPARATOR

Hemostasis after an ablation for atrial fibrillation with the Manual Hemostasis Technique.

Procedure: Ablation for atrial fibrillation.

Interventions

Ablation for atrial fibrillation.

Figure of 8 SutureManual Hemostasis Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any patient who meets standard clinical criteria for an ablation of AF with Cryoballoon, and is to undergo the procedure

You may not qualify if:

  • Pregnant patients.
  • Age \<18 years.
  • Patients who cannot provide consent in English.
  • Prisoners.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inova Fairfax Hospital

Falls Church, Virginia, 22042, United States

Location

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Vineet Kumar
Organization
Inova Heart and Vascular Institute

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2017

First Posted

February 2, 2017

Study Start

March 1, 2017

Primary Completion

March 1, 2018

Study Completion

June 1, 2018

Last Updated

January 11, 2022

Results First Posted

January 11, 2022

Record last verified: 2021-12

Locations